Abstract
The application describes the synthesis of 1H-pyrazolo[4,3-H]quinazoline compounds for treating cell proliferation dysfunction and is a broad-spectrum and strongly- active inhibitor for a cell cyclin-dependent kinase (CDK).
Keywords: : Pyrazolo-quinazoline, cyclin-dependent kinase, cancer, inflammation, cell-cycle regulation, cell proliferation.
[http://dx.doi.org/10.1038/nrc2602] [PMID: 19238148]
[http://dx.doi.org/10.3390/cancers14143380] [PMID: 35884441]
[http://dx.doi.org/10.1080/13543776.2022.2078193]
[http://dx.doi.org/10.1038/nm1468] [PMID: 16951685]
[http://dx.doi.org/10.1021/acs.jmedchem.1c02064] [PMID: 35485642]
[http://dx.doi.org/10.1039/D1RA03820F] [PMID: 35479560]
[http://dx.doi.org/10.1021/acs.jmedchem.1c02190] [PMID: 35235745]
[http://dx.doi.org/10.2217/fon-2021-0842] [PMID: 35137602]
[http://dx.doi.org/10.3390/cancers13235994] [PMID: 34885105]
[http://dx.doi.org/10.2174/1389557521666211027104957] [PMID: 34711160]
[http://dx.doi.org/10.1002/cncr.33650] [PMID: 34047359]
[http://dx.doi.org/10.2174/1389557521666210325115218] [PMID: 33823764]
[http://dx.doi.org/10.1056/NEJMoa1505270] [PMID: 26030518]
[http://dx.doi.org/10.1056/NEJMra1307118] [PMID: 33369357]
[http://dx.doi.org/10.1056/NEJMoa2114663] [PMID: 35263519]